I. Managing pain: Recent advances and new challenges

British Journal of Anaesthesia

Volumn 111, Issue 1, 2013, Pages 1-3

  Colvin, L A ^a   Rowbotham, D J ^b  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIA; CLINICAL TRIAL (TOPIC); COGNITIVE THERAPY; EDITORIAL; HUMAN; IMMUNE RESPONSE; PATIENT CARE; POSTOPERATIVE PAIN; PRIORITY JOURNAL; PSYCHOSOCIAL CARE;

EID: 84880202667     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aet222     Document Type: Editorial

References (34)

1. Colvin LA, Lambert DG. Pain medicine: advances in basic sciences and clinical practice. Br J Anaesth 2008; 101: 1-4
2. Colvin LA, Moller AM. Volume 100: clinical investigations: where next? Br J Anaesth 2008; 100: 433-5
3. Smith BH, Macfarlane GJ, Torrance N. Epidemiology of chronic pain, from the laboratory to the bus stop: time to add understanding of biological mechanisms to the study of risk factors in populationbased research? Pain 2007; 127: 5-10
4. Cervero F. Pain research: what have we learned and where are we going. Br J Anaesth 2013; 111: 6-8
5. Keefe FJ, Porter L, Somers T, Shelby R,Wren AV. Psychosocial interventions for managing pain in older adults: outcomes and clinical implications. Br J Anaesth 2013; 111: 89-94
6. Graf J. Analgesic use in the elderly: the "pain" and simple truth: comment on "The comparative safety of analgesics in older adults with arthritis". Arch Intern Med 2010; 170: 1976-8
7. Eccleston C, Morley SJ, de C. Williams AC. Psychological approaches to chronic pain management: evidence and challenges. Br J Anaesth 2013; 111: 59-63
8. Williams AC, Eccleston C, Morley S. Psychological therapies for the management of chronic pain (excluding headache) in adults. Cochrane Database Syst Rev 2012; Art. No. CD007407
9. Dworkin RH, Turk DC, Basch E, et al. Considerations for extrapolating evidence of acute and chronic pain analgesic efficacy. Pain 2011; 152: 1705-8
10. Dworkin RH, Turk DC, Katz NP, et al. Evidence-based clinical trial design for chronic pain pharmacotherapy: a blueprint for ACTION. [Review] Pain 2011; 152: S107-15
11. Dworkin RH, Turk DC, Peirce-Sandner S, et al. Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendations. [Review; 158 refs] Pain 2010; 149: 177-93
12. Moore RA, Derry S, Wiffen PJ. Challenges in design and interpretation of chronic pain trials. Br J Anaesth 2013; 111: 38-45
13. Woolf CJ, SalterMW. Neuronal plasticity-increasing the gain in pain. Science 2000; 288: 1765-8
14. Ellis A, Bennett DLH. Neuroinflammation and the generation of neuropathic pain. Br J Anaesth 2013; 111: 26-37
15. Stein C, Machelska H. Modulation of peripheral sensory neurons by the immune system: implications for pain therapy. [Review] Pharmacol Rev 2011; 63: 860-81
16. Al-Hashimi M, Scott SWM, Thompson JP, Lambert DG. Opioids and immune modulation: more questions than answers. Br J Anaesth 2013; 111: 80-8
17. Gach K, Wyrebska A, Fichna J, Janecka A. The role of morphine in regulation of cancer cell growth. [Review] Naunyn Schmiedebergs Arch Pharmacol 2011; 384: 221-30
18. Cleeland CS, Bennett GJ, Dantzer R, et al. Are the symptoms of cancerand cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms. Cancer 2003; 97: 2919-25
19. Colvin LA, Fallon MT, Buggy DJ. Cancer biology, analgesics, and anaesthetics: is there a link? Br J Anaesth 2012; 109: 140-3
20. Sikandar S, Dickenson AH. No need for translation when the same language is spoken. Br J Anaesth 2013; 111: 3-6
21. Currie G, Delaney A, Bennett MI, et al. Animal models of bone cancer pain: systematic review and meta-analyses. Pain 2013; 154: 917-26
22. Macleod M, van der Worp HB. Animal models of neurological disease: are there any babies in the bathwater? Pract Neurol 2010; 10: 312-4
23. Roberts K, Shenoy R, Anand P. A novel human volunteer pain model using contact heat evoked potentials (CHEP) following topical skin application of transient receptor potential agonists capsaicin, menthol and cinnamaldehyde. J Clin Neurosci 2011; 18: 926-32
24. Yarnitsky D, Crispel Y, Eisenberg E, et al. Prediction of chronic postoperative pain: pre-operative DNIC testing identifies patients at risk. Pain 2008; 138: 22-8
25. Aasvang EK, Gmaehle E, Hansen JB, et al. Predictive risk factors for persistent postherniotomy pain. Anesthesiology 2010; 112: 957-69
26. Lee MC, Zambreanu L, Menon DK, Tracey I. Identifying brain activity specifically related to the maintenance and perceptual consequence of central sensitization in humans. J Neurosci 2008; 28: 11642-9
27. Bingel U,WanigasekeraV,Wiech K, et al. The effect of treatmentexpectation on drug efficacy: imaging the analgesic benefit of the opioid remifentanil. Sci Transl Med 2011; 3: 70ra14
28. Tracey I. Getting the pain you expect: mechanisms of placebo, nocebo and reappraisal effects in humans. Nat Med 2010; 16: 1277-83
29. Maier C, Baron R, Tolle TR, et al. Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): somatosensory abnormalities in 1236 patients with different neuropathic pain syndromes. Pain 2010; 150: 439-50
30. Attal N, Bouhassira D, Baron R, et al. Assessing symptom profiles in neuropathic pain clinical trials: can it improve outcome? Eur J Pain 2011; 15: 441-3
31. Tracey I. Can neuroimaging studies identify pain endophenotypes in humans? Nat Rev Neurol 2011; 7: 173-81
32. Mogil JS. Pain genetics: past, presentand future. Trends Genet 2012; 28: 258-66
33. Kalso E. Persistent post-surgery pain: research agenda for mechanisms, prevention, and treatment. Br J Anaesth 2013; 111: 9-12
34. Smith BH, Lee J, Price C, Baranowski AP. Neuropathic pain: a pathway for care developed by the British Pain Society. Br J Anaesth 2013; 111: 73-9